ml 7 has been researched along with Allergic Encephalomyelitis in 1 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huppert, J | 1 |
| Closhen, D | 1 |
| Croxford, A | 1 |
| White, R | 1 |
| Kulig, P | 1 |
| Pietrowski, E | 1 |
| Bechmann, I | 1 |
| Becher, B | 1 |
| Luhmann, HJ | 1 |
| Waisman, A | 1 |
| Kuhlmann, CR | 1 |
1 other study available for ml 7 and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
Topics: Animals; Antibodies, Neutralizing; Azepines; Blood-Brain Barrier; Cell Line, Transformed; Down-Regul | 2010 |